These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8524489)

  • 21. [Nephro-protective effect of calcium antagonists].
    Deray G
    Presse Med; 1999 Oct; 28(30):1667-70. PubMed ID: 10544702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute, chronic and postwithdrawal antihypertensive and renal effects of amlodipine in hypertensive patients.
    Leonetti G; Rupoli L; Chianca R; Catarrasi C; Ruffilli MP; Zanchetti A
    J Hypertens Suppl; 1991 Dec; 9(6):S394-5. PubMed ID: 1840201
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
    Grekas D; Dioudis C; Kalevrosoglou I; Alivanis P; Derveniotis V; Tourkantonis A
    Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium antagonists and renal failure progression.
    Robles NR
    Ren Fail; 2008; 30(3):247-55. PubMed ID: 18350443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do calcium channel blockers have renal protective effects?
    Reams GP
    Drugs Aging; 1994 Oct; 5(4):263-87. PubMed ID: 7827397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS.
    Leoncini G; Martinoli C; Viazzi F; Ravera M; Parodi D; Ratto E; Vettoretti S; Tomolillo C; Derchi LE; Deferrari G; Pontremoli R
    Nephron; 2002 Feb; 90(2):169-73. PubMed ID: 11818701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal haemodynamic and protective effects of calcium antagonists in hypertension.
    Zanchi A; Brunner HR; Waeber B; Burnier M
    J Hypertens; 1995 Dec; 13(12 Pt 1):1363-75. PubMed ID: 8866898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease.
    Abe M; Okada K; Maruyama N; Matsumoto S; Maruyama T; Fujita T; Matsumoto K; Soma M
    Expert Opin Investig Drugs; 2010 Sep; 19(9):1027-37. PubMed ID: 20649501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preservation of renal function: the spectrum of effects by calcium channel blockers.
    Deray G
    Nephrol Dial Transplant; 1998 May; 13(5):1315-6. PubMed ID: 9623579
    [No Abstract]   [Full Text] [Related]  

  • 33. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium channel blockers. Progression of renal disease.
    Krishna GG; Narins RG
    Circulation; 1989 Dec; 80(6 Suppl):IV47-51. PubMed ID: 2688984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal actions of calcium antagonists.
    Sterzel RB
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S17-22. PubMed ID: 2455125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium antagonists and the kidney: implications for renal protection.
    Epstein M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S64-70. PubMed ID: 1725007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal effects of calcium entry blockers.
    Ruilope LM; Alcazar JM
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():979-82. PubMed ID: 2076410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nephrosclerosis: current status].
    Okamura M; Takeda T
    Nihon Rinsho; 1993 Aug; 51(8):2139-46. PubMed ID: 8411683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of manidipine, a new calcium antagonist, on intrarenal hemodynamics in essential hypertension.
    Murakami K; Kimura G; Imanishi M; Sanai T; Kawano Y; Kojima S; Yoshida K; Abe H; Ashida T; Yoshimi H
    Blood Press Suppl; 1992; 3():114-8. PubMed ID: 1343278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Future prospects for calcium antagonists.
    Kazda S
    Drugs; 1994; 48 Suppl 1():32-9. PubMed ID: 7533704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.